Sports performer? Palmitoylethanolamide holds potential as a CBD alternative, claims Gencor exec

The company’s new delivery method, LipiSperse boost bioavailability and applications

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

29 May 2020 --- In nutrition news this week, Givaudan is set to acquire French biotechnology company Alderys, while ESI Nutrition expanded its Ploudaniel’s facility in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

20 May 2020 --- More than a year has passed since cannabidiol (CBD) was classified as a novel food in January 2019, yet the regulatory situation regarding its safety and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

15 May 2020 --- New research is presenting a mixed picture of the health credentials of coffee. While a UK study from Anglia Ruskin University linked higher coffee consumption to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 May 2020 --- Gencor’s palmitoylethanolamide (PEA) ingredient, called Levagen+, has demonstrated almost double absorption potential when administered via Pharmako... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

12 May 2020 --- The global senior population continues to grow, with predictions saying that by the year 2060 the percentage of people over sixty will outnumber that of teenagers.... Read More

trans